Korean J Ophthalmol.  2018 Jun;32(3):204-210. 10.3341/kjo.2017.0050.

Incidence and Risk Factors of Cystoid Macular Edema after Vitrectomy with Silicone Oil Tamponade for Retinal Detachment

Affiliations
  • 1Siloam Eye Hospital, Seoul, Korea.
  • 2Department of Ophthalmology, Institute of Vision Research, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea. semekim@yuhs.ac
  • 3Department of Ophthalmology, Yonsei University Wonju College of Medicine, Wonju, Korea.

Abstract

PURPOSE
To investigate the incidence and risk factors of cystoid macular edema (CME) after silicone oil (SO) injection for retinal detachment.
METHODS
Fifty-eight patients with retinal detachment treated by vitrectomy with SO tamponade during 2011 to 2015 were retrospectively assigned to CME and non-CME groups. Patients underwent complete ophthalmological examination, including color fundus photography and preoperative and postoperative optical coherence tomography. Risk factors for CME during SO tamponade were determined by regression analyses.
RESULTS
Of the 58 eyes, 21 (36.2%) exhibited CME. The presence of posterior staphyloma in the CME group was significantly more frequent than in the non-CME group (p = 0.026). There were no significant differences in other demographic or clinical characteristics between the CME and non-CME groups. Significant correlations were observed between CME after vitrectomy with SO tamponade and the presence of posterior staphyloma (odds ratio, 4.03; p = 0.031). Of the 21 eyes with CME, 13 underwent SO removal, among which 11 experienced resolution of CME with or without further intervention.
CONCLUSIONS
The presence of posterior staphyloma is significantly associated with CME after vitrectomy with SO tamponade. Patients with retinal detachment exhibiting posterior staphyloma should be evaluated for potential CME during SO tamponade.

Keyword

Macular edema; Retinal detachment; Silicone oil

MeSH Terms

Humans
Incidence*
Macular Edema*
Photography
Retinal Detachment*
Retinaldehyde*
Retrospective Studies
Risk Factors*
Silicon*
Silicones*
Tomography, Optical Coherence
Vitrectomy*
Retinaldehyde
Silicon
Silicones

Figure

  • Fig. 1 Rhegmatogenous retinal detachment due to retinal hole in the left eye of a 75-year-old female patient. The patient had no history of hypertension or diabetes mellitus and had received cataract surgery in both eyes. Preoperative visual acuity and intraocular pressure were 0.02 Snellen units and 13 mmHg, respectively. The patient received combined vitrectomy with scleral encircling and additional laser treatment. Cystoid macular edema was detected on spectral-domain optical coherence tomography images acquired 237 days after surgery. (A) Oil removal and posterior subtenon triamcinolone injection were performed 251 days after silicone oil injection. (B) Remission of cystoid macular edema was observed on spectral-domain optical coherence tomography images acquired 1 month later.

  • Fig. 2 Rhegmatogenous retinal detachment due to retinal hole in the left eye of a 23-year-old female patient. The patient had no history of hypertension or diabetes mellitus. Preoperative visual acuity and intraocular pressure were 0.05 Snellen units and 23 mmHg, respectively. The patient received combined vitrectomy with scleral encircling and additional laser treatment. Cystoid macular edema was detected on spectral-domain optical coherence tomography images acquired 218 days after surgery. (A) Oil removal was performed 343 days after silicone oil injection. (B) However, remaining cystoid macular edema was observed on spectral-domain optical coherence tomography images acquired 293 days after oil removal.


Reference

1. Vitrectomy with silicone oil or sulfur hexafluoride gas in eyes with severe proliferative vitreoretinopathy: results of a randomized clinical trial. Silicone Study Report 1. Arch Ophthalmol. 1992; 110:770–779.
2. Vitrectomy with silicone oil or perfluoropropane gas in eyes with severe proliferative vitreoretinopathy: results of a randomized clinical trial. Silicone Study Report 2. Arch Ophthalmol. 1992; 110:780–792.
3. Laqua H, Lucke K, Foerster MH. Development and current status of silicone oil surgery. Klin Monbl Augenheilkd. 1988; 192:277–283.
4. Riedel KG, Gabel VP, Neubauer L, et al. Intravitreal silicone oil injection: complications and treatment of 415 consecutive patients. Graefes Arch Clin Exp Ophthalmol. 1990; 228:19–23.
Article
5. Casswell AG, Gregor ZJ. Silicone oil removal I The effect on the complications of silicone oil. Br J Ophthalmol. 1987; 71:893–897.
Article
6. Casswell AG, Gregor ZJ. Silicone oil removal II Operative and postoperative complications. Br J Ophthalmol. 1987; 71:898–902.
Article
7. Franks WA, Leaver PK. Removal of silicone oil: rewards and penalties. Eye (Lond). 1991; 5(Pt 3):333–337.
8. Hutton WL, Azen SP, Blumenkranz MS, et al. The effects of silicone oil removal. Silicone Study Report 6. Arch Ophthalmol. 1994; 112:778–785.
9. La Heij EC, Hendrikse F, Kessels AG. Results and complications of temporary silicone oil tamponade in patients with complicated retinal detachments. Retina. 2001; 21:107–114.
Article
10. Colin J. The role of NSAIDs in the management of postoperative ophthalmic inflammation. Drugs. 2007; 67:1291–1308.
Article
11. Rashad MA, Mohamed AA, Ahmed AI. Value of optical coherence tomography in the detection of macular pathology before the removal of silicone oil. Clin Ophthalmol. 2016; 10:121–135.
Article
12. Bae SH, Hwang JS, Yu HG. Comparative analysis of macular microstructure by spectral-domain optical coherence tomography before and after silicone oil removal. Retina. 2012; 32:1874–1883.
Article
13. Kiss CG, Richter-Muksch S, Sacu S, et al. Anatomy and function of the macula after surgery for retinal detachment complicated by proliferative vitreoretinopathy. Am J Ophthalmol. 2007; 144:872–877.
Article
14. Karahan E, Tuncer I, Zengin MO, et al. Spontaneous resolution of macular edema after silicone oil removal. Int J Ophthalmol. 2014; 7:1005–1009.
15. Lo DM, Flaxel CJ, Fawzi AA. Macular effects of silicone oil tamponade: optical coherence tomography findings during and after silicone oil removal. Curr Eye Res. 2017; 42:98–103.
Article
16. Christensen UC, la Cour M. Visual loss after use of intraocular silicone oil associated with thinning of inner retinal layers. Acta Ophthalmol. 2012; 90:733–737.
Article
17. Wolf S, Schon V, Meier P, Wiedemann P. Silicone oil-RMN3 mixture (“heavy silicone oil”) as internal tamponade for complicated retinal detachment. Retina. 2003; 23:335–342.
Article
18. Asaria RH, Kon CH, Bunce C, et al. Silicone oil concentrates fibrogenic growth factors in the retro-oil fluid. Br J Ophthalmol. 2004; 88:1439–1442.
Article
19. Funatsu H, Noma H, Mimura T, et al. Association of vitreous inflammatory factors with diabetic macular edema. Ophthalmology. 2009; 116:73–79.
Article
20. Curtin BJ. The posterior staphyloma of pathologic myopia. Trans Am Ophthalmol Soc. 1977; 75:67–86.
21. Wang NK, Wu YM, Wang JP, et al. Clinical characteristics of posterior staphylomas in myopic eyes with axial length shorter than 26.5 millimeters. Am J Ophthalmol. 2016; 162:180–190.
22. Azzolini C, Donati S, Caprani SM, et al. Macular edema and silicone oil tamponade. J Clin Exp Ophthalmol. 2014; 5:366.
Article
23. Scheerlinck LM, Schellekens PA, Liem AT, et al. Incidence, risk factors, and clinical characteristics of unexplained visual loss after intraocular silicone oil for macula-on retinal detachment. Retina. 2016; 36:342–350.
Article
Full Text Links
  • KJO
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr